Eli Lilly & Co. (LLY)
974.96
-12.09
(-1.22%)
USD |
NYSE |
May 07, 16:00
973.56
-1.40
(-0.14%)
After-Hours: 17:45
Eli Lilly Research and Development Expense (Annual) : 13.34B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Viking Therapeutics, Inc. | 344.96M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| Arcellx, Inc. | 157.61M |
| Moderna, Inc. | 2.917B |